Understand Roles of Remdesivir and Dexamethasone for COVID-19

December 2020

Remdesivir (Veklury) is now FDA-approved for all hospitalized COVID-19 patients who are at least 12 years old and weigh 40 kg or more.

But this doesn't mean it should be used more. And conflicting guidelines add to the confusion.

Be prepared to explain remdesivir's current role...especially compared to dexamethasone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote